188 related articles for article (PubMed ID: 30834836)
1. Synthesis, Screening and Docking Analysis of Hispolon Pyrazoles and Isoxazoles as Potential Antitubercular Agents.
Balaji NV; HariBabu B; Rao VU; Subbaraju GV; Nagasree KP; Kumar MMK
Curr Top Med Chem; 2019; 19(9):662-682. PubMed ID: 30834836
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.
Balaji NV; Hari Babu B; Subbaraju GV; Purna Nagasree K; Murali Krishna Kumar M
Bioorg Med Chem Lett; 2017 Jan; 27(1):11-15. PubMed ID: 27894872
[TBL] [Abstract][Full Text] [Related]
3. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization and biological screening of pyrazole-conjugated benzothiazole analogs.
Bhat M; Belagali SL
Future Med Chem; 2018 Jan; 10(1):71-87. PubMed ID: 29235357
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
Joshi SD; Dixit SR; Kirankumar MN; Aminabhavi TM; Raju KV; Narayan R; Lherbet C; Yang KS
Eur J Med Chem; 2016 Jan; 107():133-52. PubMed ID: 26580979
[TBL] [Abstract][Full Text] [Related]
7. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
8. Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis Agents.
Meta E; Brullo C; Tonelli M; Franzblau SG; Wang Y; Ma R; Baojie W; Orena BS; Pasca MR; Bruno O
Med Chem; 2019; 15(1):17-27. PubMed ID: 29792151
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
Modi P; Patel S; Chhabria M
Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
[TBL] [Abstract][Full Text] [Related]
10. 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
Velaparthi S; Brunsteiner M; Uddin R; Wan B; Franzblau SG; Petukhov PA
J Med Chem; 2008 Apr; 51(7):1999-2002. PubMed ID: 18335974
[TBL] [Abstract][Full Text] [Related]
11. Novel Aminopyrazole Tagged Hydrazones as Anti-Tubercular Agents: Synthesis and Molecular Docking Studies.
Padmini T; Bhikshapathi D; Suresh K; Kulkarni R; Kamal BR
Med Chem; 2021; 17(4):344-351. PubMed ID: 32407282
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
Pathak RB; Chovatia PT; Parekh HH
Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129
[TBL] [Abstract][Full Text] [Related]
13. Pyrazole clubbed triazolo[1,5-a]pyrimidine hybrids as an anti-tubercular agents: Synthesis, in vitro screening and molecular docking study.
Bhatt JD; Chudasama CJ; Patel KD
Bioorg Med Chem; 2015 Dec; 23(24):7711-6. PubMed ID: 26631439
[TBL] [Abstract][Full Text] [Related]
14. Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS
Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimycobacterial activity of 5-aryl-1-isonicotinoyl-3-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazole derivatives.
Mamolo MG; Zampieri D; Falagiani V; Vio L; Banfi E
Farmaco; 2001 Aug; 56(8):593-9. PubMed ID: 11601645
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.
Alegaon SG; Alagawadi KR; Dadwe DH
Drug Res (Stuttg); 2014 Oct; 64(10):553-8. PubMed ID: 24446205
[TBL] [Abstract][Full Text] [Related]
18. MoS
Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
20. Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives.
Naidu KM; Srinivasarao S; Agnieszka N; Ewa AK; Kumar MM; Chandra Sekhar KV
Bioorg Med Chem Lett; 2016 May; 26(9):2245-50. PubMed ID: 27020525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]